Sionna Therapeutics (SION) shares were down more than 92% premarket Monday after the company said that a phase 2a proof-of-concept trial for its cystic fibrosis drug, SION-719, failed to meet its primary efficacy endpoint.
Tenax Therapeutics (TENX) stock was more than 82% lower after the company said a phase 3 clinical trial of its primary drug candidate, TNX-103, failed to meet its primary endpoint.
MasterBeef Group (MB) shares were down more than 30% following an over 137% rise at Friday's close.
AirSculpt Technologies (AIRS) stock was more than 20% lower following the company's Q2 financial results.
Big Tree Cloud (DSY) shares were down 18%, swinging from the previous session's nearly 36% increase.
Comments